Tamoxifen retinopathy: Does it really exist?

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 236, Issue 9, 1998, Pages 669-673

  Lazzaroni, Franco ^a,b   Scorolli, Lucia ^a   Pizzoleo, Claudia F ^a   Savini, Giacomo ^a   De Nigris, Alessio ^c,d   Giosa, Francesco ^c,d   Meduri, Renato A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Policlinico S Orsola Malpighi ^*  (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Servizio di Oncologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; TAMOXIFEN CITRATE;

ADULT; AGED; ARTICLE; BIOMICROSCOPY; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; RETINOPATHY; SLIT LAMP; VISUAL ACUITY; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ESTROGEN ANTAGONISTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MIDDLE AGED; PREVALENCE; RETINA; RETINAL DISEASES; RETROSPECTIVE STUDIES; TAMOXIFEN; VISUAL ACUITY;

EID: 0031781143     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050139     Document Type: Article

References (21)

1. Ashford AR, Donev I, Tiwari RP, Garrett TJ (1988) Reversible ocular toxicity related to tamoxifen therapy. Cancer 61:33-35
2. Bentley CR, Davies G, Aclimandos WA (1992) Tamoxifen retinopathy: a rare but serious complication. BMJ 304:495-496
3. Bressler SB, Bressler NM, Gragoudas ES (1995) Degenerazione maculare legata all'età: drusen e atrofia a cana geografica. In: Albenrt DM, Jakobiec FA (eds) Principi e Pratica di Oftalmologia. Verduci Editore, Roma (Principles and Practice of Ophthalmology. Saunders, Philadelphia), pp 893-894
4. Chern S, Danis RP (1993) Retinopathy associated with low-dose tamoxifen. (letter) Am J Ophthalmol 116:372-373
5. Griffiths MFP (1987) Tamoxifen retinopathy at low dosage. (letter) Am J Ophthalmol 104:185-186
6. Heel RC, Brogden RN, Speight TM, Avery GS (1978) Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer. Drugs 16:1-24
7. Heier JS, Dragoo RA, Enzenauer RW, Waterhouse WJ (1994) Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Am J Ophthalmol 117:772-775
8. Kaiser-Kupfer MI, Lippman ME (1978) Tamoxifen retinopathy. Cancer Treat Rep 62:315-320
9. Kalina RE, Wells CG (1995) Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. (letter) Am J Ophthalmol 119:112-113
10. Love RR (1989) Tamoxifen therapy in primary breast cancer. Biology, efficacy, and side effects. J Clin Oncol 7:803
11. Love RR, Mazess RB, Barden HS, et al (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852-856
12. McDonald C, Stewart HJ (1991) Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. BMJ 303:435-437
13. McKeown CA, Swartz M, Blom J, Maggiano M (1981) Tamoxifen retinopathy. Br J Ophthalmol 65:177-179
14. Murphy R (1987) Epidémiologie, prévalence et facteurs de risque de néovascularisation sous-rétinienne dans la dégénérence maculaire liée a l'age. In: Coscas G, Soubrane G (eds) Neovaisseaux sous-rétiniens maculaires et laser. Doin, Paris, pp 6-13
15. Nolvadex Adjuvant Trial Organization (1985) Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer: analysis at six years. Lancet 1:171-175
16. Nolvadex Adjuvant Trial Organization (1988) Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. Br J Cancer 57:608-611
17. Pavlidis NA, Petris C, Briassoulis E, et al (1992) Clear evidence that longterm, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer 69:2961-2964
18. Powles TJ (1992) The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet 340:1145-1147
19. Pugesgaard T, Von Eyben FE (1986) Bilateral optic neuritis evolved during tamoxifen treatment. Cancer 58:383-386
20. Viladiu P, Bosch F, Benito E, Alonso MC (1977) Antiestrogen tamoxifen in the treatment of advanced breast cancer. A series of 31 patients. Cancer Treat Rep 61:899-900
21. Vinding T, Nielsen NV (1983) Retinopathy caused by treatment with tamoxifen in low dosage. Acta Ophthalmol 61:45-50